Randomized trial of safinamide add-on to levodopa in Parkinson's disease with motor fluctuations

Safinamide reduces dyskinesias and prolongs l-DOPA antiparkinsonian effect in parkinsonian monkeys

(2013) Laurent Grégoire et al.   PARKINSONISM & RELATED DISORDERS

Long-term efficacy and safety of safinamide as add-on therapy in early Parkinson's disease

(2012) A. H. V. Schapira et al.   EUROPEAN JOURNAL OF NEUROLOGY

A randomized, double-blind, placebo-controlled trial of safinamide as add-on therapy in early Parkinson's disease patients

(2011) Fabrizio Stocchi et al.   MOVEMENT DISORDERS

The Clinically Important Difference on the Unified Parkinson's Disease Rating Scale

(2010) Lisa M. Shulman et al.   ARCHIVES OF NEUROLOGY

Parkinson’s Disease and Motor Fluctuations

(2010) Vanessa K. Hinson   Current Treatment Options in Neurology

Levodopa: Past, Present, and Future

(2009) Robert A. Hauser   EUROPEAN NEUROLOGY

Levodopa therapeutics for Parkinson's disease: new developments

(2009) Peter A. LeWitt   PARKINSONISM & RELATED DISORDERS

Levodopa-Induced Dyskinesias in Parkinson’s Disease: Etiology, Impact on Quality of Life, and Treatments

(2008) Elmyra V. Encarnacion et al.   EUROPEAN NEUROLOGY